Scientists from the University of Latvia (UL) in collaboration with a Swiss research center conducted an experiment that may help diagnose and treat cancer more accurately, the university reported.
A radiopharmaceutical drug — a special medicinal substance with a small dose of radioactivity — helps doctors accurately locate and treat tumors.
The experiment demonstrated for the first time the complete cycle of developing a new theranostic radiopharmaceutical drug — from preparing special material to obtaining a radioactive medicinal substance capable of specifically targeting tumor cells. This approach allows for the integration of disease diagnosis and treatment into a single process.
Scientists explain that in the future, this could help doctors better tailor therapy for each patient and reduce side effects. This achievement is considered an important step in strengthening Latvia's competencies in the field of radiopharmaceutical research and may pave the way for clinical applications in the future.
